The planned acquisition is for Mobile laboratory tests.
LOT-0001
1 p.o.d. General and rare tests.
The planned acquisition is for Mobile laboratory tests.
LOT-0002
2 p.o.d. Infectious molecular diagnostics (PCR) and pathological tests.
The planned acquisition is for Mobile laboratory tests.